Inflammatory cells and airway remodelling in COPD: clinical implications

M. Contoli (Ferrara (FE), Italy)

Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Contoli (Ferrara (FE), Italy). Inflammatory cells and airway remodelling in COPD: clinical implications. International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inflammatory cells and airway remodelling in COPD
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019


Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019

Clinical relevance of airway remodelling in airway diseases
Source: Eur Respir J 2007; 30: 134-155
Year: 2007



Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007



Novel concepts in airway inflammation and remodelling in asthma
Source: Eur Respir J 2015; 46: 1796-1804
Year: 2015



Clinical and inflammatory determinants of (the course of) bronchial hyperresponsiveness in COPD
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010

Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012



Airway remodelling in asthma is related to particular characteristics of airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 188s
Year: 2002

Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003



Remodelling in paediatric respiratory disease and impact on growth and development
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=41
Year: 2006

Tools used to measure airway remodelling in research
Source: Eur Respir J 2007; 29: 596-604
Year: 2007



Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

The EvA-Study: Markers of emphysema versus airway disease in COPD
Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC
Year: 2009


The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014

Airway inflammatory mediators and airway wall remodelling in asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009



Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

Inflammatory cell phenotypes in bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 484s
Year: 2005